Why Is Biden Treating Monkeypox Like The New COVID?

By Seth Cutler | Sunday, 21 August 2022 04:45 PM
Views 126

The Biden administration is ramping up the allocation of monkeypox vaccines in the United States amid the stressed market, announcing projects to make an additional 1.8 million doses of the Jynneos monkeypox vaccine available in the coming days.

Keeping up with the enhanced supply, up to 50,000 doses from the Strategic National Stockpile will be referred to a new pilot program by the Department of Health and Human Services that will work with states and localities to provide vaccinations at large LGBT events.

"Jurisdictions hosting these events can request to receive additional vaccine allocations based on the size and nature of the event and the ability to reach attendees who are the highest risk of monkeypox, largely right now men who are having sex with men," CDC Director Rochelle Walensky said.

 WATCH: RFK JR. ADDRESSING HIS CHANCES TO WIN AGAINST TRUMPbell_image

The HHS has already operated with health departments in North Carolina, Georgia, and Louisiana to administer vaccines at future events, including the Charlotte Pride Festival & Parade.

Officials thought vaccinations would not prevent the spread of monkeypox, as the vaccine requires a second dose to be administered 28 days later. Vaccine recipients do not acquire full protection until two weeks after their second dose.

 GOV. ABBOTT WARNS OF EXODUS FROM THIS CITY: WHY RESIDENTS ARE FLEEING IN RECORD NUMBERSbell_image

The administration also described measures to make "50,000 patient courses" of Tpoxx available starting next week. Tpoxx, the only drug on the market to treat monkeypox currently, has been difficult to access for many people due to its limited supply.

 GOV. ABBOTT WARNS OF EXODUS FROM THIS CITY: WHY RESIDENTS ARE FLEEING IN RECORD NUMBERSbell_image

Over 13,500 cases of monkeypox have been identified across 49 states and Washington, D.C. Data show that 98% of the current cases are occurring in men, and 93% of cases are among men who reported recent sexual history with other men, Walensky said.

 GOV. ABBOTT WARNS OF EXODUS FROM THIS CITY: WHY RESIDENTS ARE FLEEING IN RECORD NUMBERSbell_image

Hitherto, the Biden-Harris Administration has delivered nearly 1 million doses of JYNNEOS vaccine to jurisdictions – the world's largest JYNNEOS MPV vaccine program. Last week, the Food and Drug Administration (FDA) announced the Emergency Use Authorization of the JYNNEOS vaccine to be issued intradermally in individuals 18 years of age and older determined to be more susceptible to MPV, without compromising the level of immune response achieved or the safety of the vaccine. The action means that each vaccine vial can be used for up to five doses, since the appropriate dose for intradermal administration is 0.1mL versus 0.5mL required per dose administered subcutaneously. Paired with that announcement, the Centers for Disease Control and Prevention (CDC) released a robust set of resources and tools to help jurisdictions train providers and health care professionals on how to administer the vaccine intradermally.

 WATCH: UK MUSLIM: 'ISLAM REJECTS YOUR LAWS'bell_image

In less than ten days after FDA’s EUA on intradermal administration, some of the country’s largest counties have shifted entirely to intradermal administration of the JYNNEOS vaccine for eligible adults, including Los Angeles County, California, and Fulton County, Georgia.

X